The “Kazakhstan Halkyna” Public Fund continues to supply medicines to Kazakhstanis with severe and rare diseases. The “Sabril” medicinal product for a total of 4.4 million tenge was supplied at the end of February and at the beginning of March 2023 to the health departments of 5 regions for 88 children diagnosed with epilepsy.
21 children in Turkestan Oblast, 24 children in Shymkent, 18 children in Pavlodar Oblast, 12 children in North Kazakhstan Oblast and 13 children in Akmola Oblast will be provided with this medicine.
The provision of the Sabril medicine was organized by the Swixx BioPharma company exclusively based o4n to the pre-order.
Since last year, the Kazakhstan Halkyna Fund has in total provided medicines to 236 patients with severe life-threatening and chronic diseases in the amount of more than 16.1 billion tenge. Of these, 230 are patients with rare (orphan) diseases, including 204 children.
Epilepsy is a chronic brain disorder characterized by repeated, basically unprovoked attacks of disorders of motor, sensory, vegetative, thinking or mental functions resulting from excessive neural discharges in the cerebral cortex.
According to WHO, up to 50 million people suffer from epilepsy worldwide, but only 25% of them are provided with adequate medical treatment. Meanwhile, modern medicines make it possible to completely free a person from seizures in 70% of cases. Such drugs are effective and low-toxic, do not affect the psyche and mood.
There are more than 45 thousand people with epilepsy in Kazakhstan, about 40% of them are children.
Sources: Press center of “Kazakhstan Halkyna” Public Fund, Pharmaceutical Review of Kazakhstan.
21 children in Turkestan Oblast, 24 children in Shymkent, 18 children in Pavlodar Oblast, 12 children in North Kazakhstan Oblast and 13 children in Akmola Oblast will be provided with this medicine.
The provision of the Sabril medicine was organized by the Swixx BioPharma company exclusively based o4n to the pre-order.
Since last year, the Kazakhstan Halkyna Fund has in total provided medicines to 236 patients with severe life-threatening and chronic diseases in the amount of more than 16.1 billion tenge. Of these, 230 are patients with rare (orphan) diseases, including 204 children.
Epilepsy is a chronic brain disorder characterized by repeated, basically unprovoked attacks of disorders of motor, sensory, vegetative, thinking or mental functions resulting from excessive neural discharges in the cerebral cortex.
According to WHO, up to 50 million people suffer from epilepsy worldwide, but only 25% of them are provided with adequate medical treatment. Meanwhile, modern medicines make it possible to completely free a person from seizures in 70% of cases. Such drugs are effective and low-toxic, do not affect the psyche and mood.
There are more than 45 thousand people with epilepsy in Kazakhstan, about 40% of them are children.
Sources: Press center of “Kazakhstan Halkyna” Public Fund, Pharmaceutical Review of Kazakhstan.
